Purpose. Mesenchymal stem cells (MSCs) have been applied in maxillary sinus augmentation (MSA) with clinically successful results. The purpose of this article was to evaluate the systematically acquired evidence for the effectiveness of cell-based approaches in MSA with various scaffolds, and to narratively assess evidence from additional articles that report effectiveness of cell-based approaches in MSA. Materials and Methods. Electronic database searches were performed. Inclusion criteria were studies of cell-based approaches in MSA with various scaffolds, in humans, with at least 3 to 4 months of follow-up. Meta-analysis was performed for randomized controlled trials (RCTs) with histologic/histomorphometric evaluation. Results. Fifteen studies (4 RCTs) were considered to be eligible for inclusion in the review. The meta-analysis suggested a marginal, nonstatistically significant positive effect of MSCs on the bone regrowth. Conclusions. A number of studies have demonstrated the potential for cell-based approaches in MSA; further RCTs that clearly demonstrate benefits of cell-based approach are needed.

Maxillary sinus augmentation with adult mesenchymal stem cells: a review of the current literature

TETTAMANTI, LUCIA;Azzi, L.;CAPRIOGLIO, ALBERTO;MANGANO, CARLO
2013-01-01

Abstract

Purpose. Mesenchymal stem cells (MSCs) have been applied in maxillary sinus augmentation (MSA) with clinically successful results. The purpose of this article was to evaluate the systematically acquired evidence for the effectiveness of cell-based approaches in MSA with various scaffolds, and to narratively assess evidence from additional articles that report effectiveness of cell-based approaches in MSA. Materials and Methods. Electronic database searches were performed. Inclusion criteria were studies of cell-based approaches in MSA with various scaffolds, in humans, with at least 3 to 4 months of follow-up. Meta-analysis was performed for randomized controlled trials (RCTs) with histologic/histomorphometric evaluation. Results. Fifteen studies (4 RCTs) were considered to be eligible for inclusion in the review. The meta-analysis suggested a marginal, nonstatistically significant positive effect of MSCs on the bone regrowth. Conclusions. A number of studies have demonstrated the potential for cell-based approaches in MSA; further RCTs that clearly demonstrate benefits of cell-based approach are needed.
2013
TISSUE-ENGINEERED BONE, AUTOGENOUS BONE, HISTOLOGIC EVALUATION, OSTEOGENIC DIFFERENTIATION, FLOOR AUGMENTATION, STROMAL CELLS, DONOR AGE, MARROW, HYDROXYAPATITE, SCAFFOLDS
Mangano, F. G.; Tettamanti, Lucia; Sammons, R. L.; Azzi, L.; Caprioglio, Alberto; Macchi, A.; Mangano, Carlo
File in questo prodotto:
File Dimensione Formato  
Vol_115_No_6.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: DRM non definito
Dimensione 257.55 kB
Formato Adobe PDF
257.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1781344
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 15
social impact